Stay updated on GLPG2222 in Ivacaftor-treated CF: Clinical Trial
Sign up to get notified when there's something new on the GLPG2222 in Ivacaftor-treated CF: Clinical Trial page.

Latest updates to the GLPG2222 in Ivacaftor-treated CF: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe sponsor field now lists Lakefront Biotherapeutics NV instead of Galapagos NV. This reflects a transition of sponsorship for the study.SummaryDifference0.2%

- Check18 days agoChange DetectedThe page's revision label updates from v3.5.3 to v3.5.4, reflecting an update to the page's backend or UI. This change does not alter the study details, eligibility, locations, or outcomes.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s footer shows an updated ClinicalTrials.gov interface revision (from v3.5.2 to v3.5.3). This reflects a system/version update rather than a change to the clinical trial information.SummaryDifference0.0%

- Check46 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check75 days agoChange DetectedSite revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

Stay in the know with updates to GLPG2222 in Ivacaftor-treated CF: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG2222 in Ivacaftor-treated CF: Clinical Trial page.